Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis

Goichi Matsumoto, Rie Hirohata, Kousuke Hayashi, Yoko Sugimoto, Eiji Kotani, Junji Shimabukuro, Tomoko Hirano, Yumiko Nakajima, Shin Kawamata, Hajime Mori

研究成果: ジャーナルへの寄稿記事

14 引用 (Scopus)

抄録

Encapsulation of cytokines within protein microcrystals (polyhedra) is a promising approach for the stabilization and delivery of therapeutic proteins. Here, we investigate the influence of vascular endothelial growth factor (VEGF) microcrystals and endostatin microcrystals on angiogenesis. VEGF was successfully encapsulated into microcrystals derived from insect cypovirus with overexpression of protein disulfide bond isomerase. VEGF microcrystals were observed to increase the phosphorylation of p42/p44 MAP kinase and to stimulate the proliferation, migration, and network and tube formation of human umbilical vein endothelial cells (HUVECs). Endostatin was also successfully encapsulated into microcrystals. Endostatin microcrystals showed antiangiogenesis activities and inhibited the migration, and network and tube formation of HUVECs. Local administration of endostatin microcrystals in mice inhibited both angiogenesis and tumor growth with clear significant differences between treatment and control groups. Endostatin microcrystals only affected angiogenesis, but had no significant effect on lymphangiogenesis compared to controls. Local therapy using endostatin microcrystals offers a potential approach to achieve sustained therapeutic release of antiangiogenic molecules for cancer treatment.

元の言語英語
ページ(範囲)1326-1333
ページ数8
ジャーナルBiomaterials
35
発行部数4
DOI
出版物ステータス出版済み - 1 1 2014

Fingerprint

Endostatins
Microcrystals
Vascular Endothelial Growth Factor A
Tumors
Proteins
Neoplasms
Human Umbilical Vein Endothelial Cells
Reoviridae
Lymphangiogenesis
Protein Disulfide-Isomerases
Endothelial cells
Mitogen-Activated Protein Kinase 1
Insects
Intercellular Signaling Peptides and Proteins
Therapeutics
Isomerases
Phosphorylation
Oncology
Cytokines
Control Groups

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

これを引用

Matsumoto, G., Hirohata, R., Hayashi, K., Sugimoto, Y., Kotani, E., Shimabukuro, J., ... Mori, H. (2014). Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis. Biomaterials, 35(4), 1326-1333. https://doi.org/10.1016/j.biomaterials.2013.10.051

Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis. / Matsumoto, Goichi; Hirohata, Rie; Hayashi, Kousuke; Sugimoto, Yoko; Kotani, Eiji; Shimabukuro, Junji; Hirano, Tomoko; Nakajima, Yumiko; Kawamata, Shin; Mori, Hajime.

:: Biomaterials, 巻 35, 番号 4, 01.01.2014, p. 1326-1333.

研究成果: ジャーナルへの寄稿記事

Matsumoto, G, Hirohata, R, Hayashi, K, Sugimoto, Y, Kotani, E, Shimabukuro, J, Hirano, T, Nakajima, Y, Kawamata, S & Mori, H 2014, 'Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis', Biomaterials, 巻. 35, 番号 4, pp. 1326-1333. https://doi.org/10.1016/j.biomaterials.2013.10.051
Matsumoto, Goichi ; Hirohata, Rie ; Hayashi, Kousuke ; Sugimoto, Yoko ; Kotani, Eiji ; Shimabukuro, Junji ; Hirano, Tomoko ; Nakajima, Yumiko ; Kawamata, Shin ; Mori, Hajime. / Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis. :: Biomaterials. 2014 ; 巻 35, 番号 4. pp. 1326-1333.
@article{88bfdcda99d04309abe64f021834f2b0,
title = "Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis",
abstract = "Encapsulation of cytokines within protein microcrystals (polyhedra) is a promising approach for the stabilization and delivery of therapeutic proteins. Here, we investigate the influence of vascular endothelial growth factor (VEGF) microcrystals and endostatin microcrystals on angiogenesis. VEGF was successfully encapsulated into microcrystals derived from insect cypovirus with overexpression of protein disulfide bond isomerase. VEGF microcrystals were observed to increase the phosphorylation of p42/p44 MAP kinase and to stimulate the proliferation, migration, and network and tube formation of human umbilical vein endothelial cells (HUVECs). Endostatin was also successfully encapsulated into microcrystals. Endostatin microcrystals showed antiangiogenesis activities and inhibited the migration, and network and tube formation of HUVECs. Local administration of endostatin microcrystals in mice inhibited both angiogenesis and tumor growth with clear significant differences between treatment and control groups. Endostatin microcrystals only affected angiogenesis, but had no significant effect on lymphangiogenesis compared to controls. Local therapy using endostatin microcrystals offers a potential approach to achieve sustained therapeutic release of antiangiogenic molecules for cancer treatment.",
author = "Goichi Matsumoto and Rie Hirohata and Kousuke Hayashi and Yoko Sugimoto and Eiji Kotani and Junji Shimabukuro and Tomoko Hirano and Yumiko Nakajima and Shin Kawamata and Hajime Mori",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.biomaterials.2013.10.051",
language = "English",
volume = "35",
pages = "1326--1333",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis

AU - Matsumoto, Goichi

AU - Hirohata, Rie

AU - Hayashi, Kousuke

AU - Sugimoto, Yoko

AU - Kotani, Eiji

AU - Shimabukuro, Junji

AU - Hirano, Tomoko

AU - Nakajima, Yumiko

AU - Kawamata, Shin

AU - Mori, Hajime

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Encapsulation of cytokines within protein microcrystals (polyhedra) is a promising approach for the stabilization and delivery of therapeutic proteins. Here, we investigate the influence of vascular endothelial growth factor (VEGF) microcrystals and endostatin microcrystals on angiogenesis. VEGF was successfully encapsulated into microcrystals derived from insect cypovirus with overexpression of protein disulfide bond isomerase. VEGF microcrystals were observed to increase the phosphorylation of p42/p44 MAP kinase and to stimulate the proliferation, migration, and network and tube formation of human umbilical vein endothelial cells (HUVECs). Endostatin was also successfully encapsulated into microcrystals. Endostatin microcrystals showed antiangiogenesis activities and inhibited the migration, and network and tube formation of HUVECs. Local administration of endostatin microcrystals in mice inhibited both angiogenesis and tumor growth with clear significant differences between treatment and control groups. Endostatin microcrystals only affected angiogenesis, but had no significant effect on lymphangiogenesis compared to controls. Local therapy using endostatin microcrystals offers a potential approach to achieve sustained therapeutic release of antiangiogenic molecules for cancer treatment.

AB - Encapsulation of cytokines within protein microcrystals (polyhedra) is a promising approach for the stabilization and delivery of therapeutic proteins. Here, we investigate the influence of vascular endothelial growth factor (VEGF) microcrystals and endostatin microcrystals on angiogenesis. VEGF was successfully encapsulated into microcrystals derived from insect cypovirus with overexpression of protein disulfide bond isomerase. VEGF microcrystals were observed to increase the phosphorylation of p42/p44 MAP kinase and to stimulate the proliferation, migration, and network and tube formation of human umbilical vein endothelial cells (HUVECs). Endostatin was also successfully encapsulated into microcrystals. Endostatin microcrystals showed antiangiogenesis activities and inhibited the migration, and network and tube formation of HUVECs. Local administration of endostatin microcrystals in mice inhibited both angiogenesis and tumor growth with clear significant differences between treatment and control groups. Endostatin microcrystals only affected angiogenesis, but had no significant effect on lymphangiogenesis compared to controls. Local therapy using endostatin microcrystals offers a potential approach to achieve sustained therapeutic release of antiangiogenic molecules for cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=84888438732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888438732&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2013.10.051

DO - 10.1016/j.biomaterials.2013.10.051

M3 - Article

C2 - 24210874

AN - SCOPUS:84888438732

VL - 35

SP - 1326

EP - 1333

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 4

ER -